Page 1
Burtom Tibbi Tahill Laboratuvarlari
55 Diamond Road
CRUMLIN BT29 4QY
Tel: +44 (0)28 9445 4399
Fax: +44 (0)28 9445 4398
Randox Laboratories Limited
ABC
LABORATORY REF. NO. 152562/E
Email: [email protected] Page 1
Authorised by: Stephen Doherty, RIQAS Manager Issue No: 1 Issue Date: 03/03/2016
MONTHLY IMMUNOASSAY
RIQAS
CYCLE 14 SAMPLE 2
Explanation of codes used in this report
R - Results removed due to reconstitution error
N - No result returned
C - Result corrected
Page 2
All Methods
Roche Elecsys
N Mean CV% U SDPA
1375 237.283 10.7 0.86 21.78
55 241.201 8.1 3.29 22.14
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
254.800 0.61
-1.14
241.201 93
84
AFP, ng/ml
%DEV
RM%DEV
5.6
-11.0
m
< 170.67 189.70 208.73 227.76 246.79 265.82 284.85 303.88 >
0
20
40
60
80
100
120
140
160
180
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
217.3
12
M
65.0
72
M
13.6
78
M
141.8
80
M
114.3
06
M
250.7
93
M
74.2
15
M
15.4
05
M
135.9
53
M
44.4
62
M
159.3
00
M
70.9
41
M
241.2
01
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 15.1%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
21.9%
15.10%RIQAS
Method N Mean CV% U
Abbott Architect 264 213.705 3.7 0.61
Roche Cobas 6000/8000 259 246.500 5.4 1.04
Roche Cobas 4000/e411 158 251.856 7.2 1.80
Siemens Centaur XP/XPT/Classic 146 278.092 5.7 1.65
Beckman DxI 600 / 800 115 220.310 6.7 1.72
Siemens/DPC Immulite 2000/2500 60 225.458 5.7 2.06
Roche Elecsys 55 241.201 8.1 3.29
bioMerieux, Vidas/Mini Vidas 48 226.685 8.8 3.60
Beckman Access/LXi725 40 239.607 7.8 3.72
Roche Modular E170 36 247.592 5.0 2.57
DiaSorin, Liaison 28 232.143 8.9 4.86
Tosoh 23 214.253 6.7 3.76
Siemens/DPC Immulite 1000 18 233.258 10.7 7.36
Ortho Vitros 3600/5600/ECi 18 274.274 9.8 7.89
CIS, IRMA 19 369.533 11.5 12.21
Siemens Centaur CP 14 282.494 9.1 8.55
Fujirebio Lumipulse G 14 237.704 1.9 1.52
Siemens Dimension 4 250.977 1.3 2.03
SNIBE Maglumi analysers 5 208.695 10.7 12.45
Brahms Kryptor 2 253.042 0.2 0.49
ELISA 2 174.413 39.9 61.54
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 50 100 150 200 250
Concentration
Page 2Issue No: 1 Issue Date: 03/03/2016
Exc.
107
10
Page 3
All Methods
Roche Elecsys
N Mean CV% U SDPA
1418 227.876 16.1 1.22 18.01
62 222.157 6.4 2.26 17.56
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
217.600 -0.26
0.00
222.157 120
106
CA 125, U/ml
%DEV
RM%DEV
-2.1
0.0
m
< 131.68 159.16 186.65 214.13 241.61 269.10 296.58 324.06 >
0
50
100
150
200
250
300
350
U/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
429.7
13
M
210.2
84
M
50.3
85
M
327.0
09
M
247.2
84
M
280.5
32
M
132.5
16
M
31.9
53
M
116.5
32
M
60.3
46
M
150.7
11
M
102.3
91
M
222.1
57
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 13%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
35.4%
13.00%RIQAS
Method N Mean CV% U
Abbott Architect 278 289.956 7.0 1.51
Roche Cobas 6000/8000 267 218.624 3.9 0.66
Roche Cobas 4000/e411 168 221.735 4.9 1.04
Centaur XP/XPT/Classic, CA125 II Kit 110 220.669 5.4 1.42
Beckman DxI 600 / 800 110 172.907 5.4 1.12
bioMerieux, VIDAS 79 242.013 6.5 2.22
Roche Elecsys 62 222.157 6.4 2.26
Siemens/DPC Immulite 2000/2500 41 208.080 6.6 2.66
Siemens Centaur XP/XPT/Classic OV Kit 37 226.592 6.6 3.06
Roche Modular E170 36 215.329 3.5 1.59
Beckman Access/LXi725 33 166.438 8.6 3.13
TOSOH 25 373.574 8.3 7.76
Ortho Vitros 3600/5600/ECi 22 215.027 3.6 2.08
Siemens/DPC Immulite 1000 22 246.782 6.1 4.03
Diasorin, Liaison 20 286.748 7.0 5.61
Siemens Centaur CP, CA125 II Kit 17 228.437 7.3 5.07
Fujirebio Lumipulse G 16 207.488 4.8 3.14
CIS, IRMA 12 164.182 6.5 3.86
SNIBE Maglumi analysers 5 269.670 25.2 38.03
Siemens Dimension 4 337.450 2.6 5.51
Brahms Kryptor 3 82.817 8.3 4.98
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
10 60 110 160 210 260 310 360 410
Concentration
Page 3Issue No: 1 Issue Date: 03/03/2016
Exc.
98
8
Page 4
All Methods
Roche Elecsys
N Mean CV% U SDPA
1057 84.123 11.8 0.38 7.26
50 87.443 9.8 1.51 7.55
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
95.560 1.08
-0.18
87.443 68
94
CA 15-3, U/ml
%DEV
RM%DEV
9.3
-1.6
m
< 57.98 65.45 72.92 80.38 87.85 95.32 102.79 110.25 >
0
20
40
60
80
100
120
140
160
180
U/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
92.2
60
M
43.6
04
M
20.7
47
M
69.0
18
M
57.1
83
M
99.0
71
M
47.8
93
M
23.1
02
M
49.0
16
M
29.5
22
M
58.6
36
M
43.2
97
M
87.4
43
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 14.2%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
20.8%
14.20%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 222 89.648 4.9 0.37
Abbott Architect 221 83.635 6.8 0.48
Siemens Centaur XP/XPT/Classic 126 84.590 6.8 0.64
Roche Cobas 4000/e411 125 89.198 8.1 0.81
Beckman DxI 600 / 800 93 34.572 5.8 0.26
BioMerieux VIDAS 54 74.088 4.8 0.60
Roche Elecsys 50 87.443 9.8 1.51
Beckman Access/LXi725 30 34.511 8.1 0.64
Siemens/DPC Immulite 2000/2500 28 75.553 7.1 1.26
Roche Modular E170 31 88.265 5.8 1.15
Diasorin, Liaison 23 81.070 9.1 1.92
TOSOH 16 84.271 14.9 3.92
Siemens/DPC Immulite 1000 17 86.295 15.2 3.98
Ortho Vitros 3600/5600/ECi 11 82.939 3.5 1.08
Fujirebio Lumipulse G 13 84.331 10.4 3.03
CIS, IRMA 11 82.976 6.3 1.96
Siemens Centaur CP 8 86.575 14.0 5.36
Brahms Kryptor 3 93.933 10.1 6.86
Siemens Dimension 3 73.667 5.1 2.71
SNIBE Maglumi analysers 3 55.151 46.8 18.62
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
10 20 30 40 50 60 70 80 90 100
Concentration
Page 4Issue No: 1 Issue Date: 03/03/2016
Exc.
146
5
Page 5
All Methods
Roche Elecsys
N Mean CV% U SDPA
1223 216.700 53.8 4.17 20.95
54 147.719 8.3 2.10 14.28
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
148.100 0.03
-0.02
147.719 120
97
CA 19-9, U/ml
%DEV
RM%DEV
0.3
-0.2
m
< 35.39 106.18 176.98 247.77 318.56 389.35 460.14 530.94 >
0
50
100
150
200
250
300
350
400
450
U/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
508.8
44
M
217.6
62
M
74.4
45
M
361.8
10
M
283.3
69
M
498.9
60
M
217.7
36
M
74.5
07
M
74.5
42
M
38.6
87
M
89.4
61
M
67.6
17
M
147.7
19
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 15.9%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
46.03%
15.90%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 256 146.635 4.7 0.54
Abbott Architect 146 543.709 8.1 4.56
Siemens Centaur XP/XPT/Classic 141 227.388 6.9 1.66
Roche Cobas 4000/e411 131 149.265 8.4 1.36
Beckman DxI 600 / 800 106 169.150 5.2 1.06
Abbott Architect XR/ XR2 kit 83 552.295 7.1 5.34
bioMerieux, VIDAS 70 271.761 5.5 2.25
Roche Elecsys 54 147.719 8.3 2.10
Siemens/DPC Immulite 2000/2500 43 198.992 11.8 4.47
Roche Modular E170 34 147.204 3.2 1.00
Diasorin, Liaison 25 209.466 12.8 6.68
Beckman Access/LXi725 24 177.579 7.6 3.44
TOSOH 20 112.540 4.0 1.25
Ortho Vitros 3600/5600/ECi 18 326.272 3.1 3.02
Siemens Centaur CP 16 237.297 10.1 7.49
CIS, IRMA 16 97.543 17.2 5.24
Siemens/DPC Immulite 1000 15 180.667 23.7 13.80
Fujirebio Lumipulse G 14 263.943 3.7 3.28
Siemens Dimension 5 224.660 6.3 7.86
SNIBE Maglumi analysers 5 114.683 26.4 16.94
Brahms Kryptor 4 161.438 6.2 6.23
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
10 110 210 310 410 510
Concentration
Page 5Issue No: 1 Issue Date: 03/03/2016
Exc.
117
6
Page 6
All Methods
Roche Integra
N Mean CV% U SDPA
251 16.367 8.6 0.11 1.38
18 18.203 7.8 0.42 1.54
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
17.480 -0.47
0.04
18.203 104
108
Carbamazepine, ug/ml
%DEV
RM%DEV
-4.0
0.4
m
< 12.67 13.73 14.78 15.84 16.89 17.94 19.00 20.05 >
0
5
10
15
20
25
30
35
40
ug/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
17.4
69
M
9.0
68
M
3.7
79
M
13.0
44
M
9.9
82
M
17.8
46
M
9.0
05
M
3.7
84
M
10.2
91
M
6.2
97
M
12.7
47
M
8.8
22
M
18.2
03
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 13.9%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
N/A
13.90%RIQAS
Method N Mean CV% U
Abbott Architect 85 16.129 7.5 0.16
Roche Cobas 6000/8000 44 16.267 6.9 0.21
Roche Integra 18 18.203 7.8 0.42
Siemens Centaur XP/XPT/Classic 11 17.885 13.9 0.93
Siemens/DPC Immulite 2000/2500 15 14.703 7.7 0.37
Vitros 14 16.204 7.2 0.39
Siemens/DPC Immulite 1000 12 14.999 6.9 0.37
Siemens Dimension 9 16.631 5.0 0.35
Beckman DxC 10 17.335 4.6 0.32
Beckman AU400/600/640/2700/5400 8 17.316 2.1 0.16
Siemens ADVIA 1200/1650/1800/2400 6 17.430 8.4 0.75
Roche Cobas 4000/c311 5 15.880 2.8 0.24
Siemens Syva/Emit 4 17.025 3.2 0.34
Siemens Centaur CP 1 25.160 0.0 0.00
Randox Rx Daytona/Imola 2 18.355 8.1 1.32
Beckman Synchron CX/LX 2 17.350 2.0 0.31
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 2 4 6 8 10 12 14 16 18 20
Concentration
Page 6Issue No: 1 Issue Date: 03/03/2016
Exc.
28
3
Page 7
All Methods
Roche Elecsys
N Mean CV% U SDPA
1469 52.435 12.2 0.21 4.30
65 48.266 8.4 0.63 3.96
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
47.860 -0.10
0.17
48.266 120
100
CEA, ng/ml
%DEV
RM%DEV
-0.8
1.3
m
< 35.59 40.40 45.21 50.02 54.84 59.65 64.46 69.27 >
0
50
100
150
200
250
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
41.5
73
M
20.7
11
M
3.8
82
M
31.7
84
M
22.8
21
M
50.1
91
M
23.1
42
M
4.0
43
M
26.8
50
M
13.5
41
M
35.2
01
M
22.6
55
M
48.2
66
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 13.5%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
24.7%
13.50%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 300 47.850 4.2 0.14
Abbott Architect 293 59.620 4.9 0.21
Roche Cobas 4000/e411 174 49.379 5.7 0.27
Siemens Centaur XP/XPT/Classic 158 57.685 4.3 0.25
Beckman DxI 600 / 800 124 48.257 6.6 0.36
Roche Elecsys 65 48.266 8.4 0.63
bioMerieux, VIDAS 57 51.364 6.0 0.51
Siemens/DPC Immulite 2000/2500 43 71.795 6.5 0.89
Beckman Access/LXi725 40 49.980 8.7 0.86
Roche Modular E170 38 47.599 5.6 0.54
Diasorin, Liaison 31 50.082 7.4 0.84
Tosoh 29 80.741 3.8 0.71
Ortho Vitros 3600/5600/ECi 23 58.764 4.0 0.61
Siemens/DPC Immulite 1000 20 73.775 8.7 1.79
Siemens Centaur CP 18 56.967 4.9 0.82
CIS, RIA Coated tube 20 40.461 6.0 0.68
Fujirebio Lumipulse G 14 72.857 3.1 0.75
Siemens Dimension 5 52.160 2.9 0.86
SNIBE Maglumi analysers 5 39.572 7.6 1.68
Brahms Kryptor 2 36.365 10.9 3.49
Immunotech IRMA 2 34.800 35.4 10.87
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
0 10 20 30 40 50
Concentration
Page 7Issue No: 1 Issue Date: 03/03/2016
Exc.
123
4
Page 8
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
1054 32.522 11.3 0.14 2.91
171 33.048 8.9 0.28 2.95
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
28.120 -1.67
-0.47
33.048 49
91
Cortisol, ug/dl
%DEV
RM%DEV
-14.9
-4.3
m
< 22.85 25.61 28.37 31.14 33.90 36.66 39.42 42.19 >
0
20
40
60
80
100
120
140
ug/dl
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
38.1
82
M
25.1
37
M
6.3
10
M
32.2
28
M
22.1
43
M
38.0
49
M
24.7
90
M
6.1
03
M
21.4
33
M
14.5
34
M
29.3
23
M
21.8
29
M
33.0
48
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 14.7%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
22.8%
14.70%RIQAS
TS & %DEV outside limits
Method N Mean CV% U
Abbott Architect 175 28.376 5.7 0.15
Roche Cobas 6000/8000 171 33.048 8.9 0.28
Roche Cobas 4000/e411 127 33.703 8.3 0.31
Siemens Centaur XP/XPT/Classic 128 37.619 8.2 0.34
Beckman DxI 600 / 800 83 31.741 7.5 0.33
Siemens/DPC Immulite 2000/2500 50 32.967 6.3 0.37
Roche Elecsys 50 34.266 9.6 0.58
Roche Cobas 6000/8000 Gen II 41 29.649 6.3 0.37
Beckman Access/LXi725 32 32.891 6.9 0.50
Roche Modular E170 33 33.307 8.9 0.64
bioMerieux, VIDAS 29 30.686 8.7 0.62
Tosoh 21 34.798 5.8 0.55
Ortho Vitros 3600/5600/ECi 15 31.437 1.2 0.13
Siemens/DPC Immulite 1000 16 35.524 6.1 0.68
CIS, RIA 16 28.661 8.7 0.78
Roche Cobas 4000/e411 Gen II 10 31.799 6.5 0.82
Diasorin, Liaison 8 35.242 3.7 0.58
Siemens Centaur CP 6 36.329 9.0 1.66
Roche Modular E170 Gen II 5 29.529 3.2 0.53
Roche Elecsys Gen II 4 32.828 12.4 2.55
SNIBE Maglumi analysers 4 41.097 13.2 3.38
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 5 10 15 20 25 30 35 40
Concentration
Page 8Issue No: 1 Issue Date: 03/03/2016
Exc.
77
11
Page 9
All Methods
Abbott Architect
N Mean CV% U SDPA
267 5.128 19.4 0.08 0.94
39 4.214 10.1 0.09 0.77
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
4.780 0.73
0.03
4.214 85
107
C-Peptide, ng/ml
%DEV
RM%DEV
13.4
0.6
m
< 2.51 3.26 4.00 4.75 5.50 6.24 6.99 7.74 >
0
5
10
15
20
25
30
35
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 N 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
4.2
59
M
3.1
46
M
1.1
77
M
3.7
65
M
2.8
89
M
4.4
15
M
2.9
65
M
1.2
18
M
2.9
46
M
2.1
32
M
2.8
32
M
4.2
14
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 N 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 30.1%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
20.8%
30.10%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 52 6.176 5.8 0.06
Abbott Architect 39 4.214 10.1 0.09
Roche Cobas 4000/e411 40 5.827 11.7 0.13
Siemens/DPC Immulite 2000/2500 33 4.392 12.2 0.12
Siemens Centaur XP/XPT/Classic 30 4.858 11.3 0.12
TOSOH 14 3.952 12.2 0.16
Diasorin, Liaison 12 7.403 19.6 0.52
Siemens/DPC Immulite 1000 9 4.731 9.7 0.19
Roche Elecsys 9 5.984 10.1 0.25
Roche Modular E170 7 5.785 6.4 0.17
DIAsource, RIA 3 5.275 31.2 1.19
ELISA 2 4.535 23.9 0.96
SNIBE Maglumi analysers 3 5.303 38.9 1.49
Fujirebio Lumipulse G 2 4.875 10.9 0.47
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 N 1 2
-40
-30
-20
-10
0
10
20
30
40
Sample Number
% D
evia
tion
>=
<=
-40
-30
-20
-10
0
10
20
30
40
% D
evia
tion
>=
<=
0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0 4.5
Concentration
Page 9Issue No: 1 Issue Date: 03/03/2016
Exc.
19
4
Page 10
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
513 7926.400 17.4 76.07 886.67
89 9408.440 4.4 54.521052.44
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
9332.000 -0.07
0.03
9408.440 120
118
DHEA-S, ng/ml
%DEV
RM%DEV
-0.8
0.4
m
< 4307.49 5341.46 6375.44 7409.41 8443.38 9477.35 10511.33 11545.30 >
0
10
20
30
40
50
60
70
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 N 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
11203.7
44
M
7156.1
85
M
1061.5
73
M
6469.6
94
M
10100.2
26
M
6672.1
36
M
2032.2
07
M
5860.0
27
M
4017.0
88
M
8412.8
18
M
6178.4
70
M
9408.4
40
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 N 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 18.4%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
10.9%
18.40%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 89 9408.440 4.4 54.52
Abbott Architect 83 7521.252 5.2 53.33
Roche Cobas 4000/e411 72 9155.191 6.8 92.33
Siemens/DPC Immulite 2000/2500 66 6571.503 6.3 63.26
Beckman DxI 600 / 800 33 6485.436 8.6 121.67
Siemens Centaur XP/XPT/Classic 32 6116.304 8.2 110.96
Roche Elecsys 31 9159.078 6.5 134.26
Siemens/DPC Immulite 1000 20 7060.270 13.0 256.30
Roche Modular E170 16 9438.876 5.5 163.11
Diasorin, Liaison 9 6159.172 16.0 410.56
TOSOH 9 8440.413 3.5 124.22
Beckman Access/LXi725 8 6593.597 3.2 94.11
Immunotech RIA 4 5965.361 9.9 370.59
ELISA 3 7299.617 27.7 1458.56
SNIBE Maglumi analysers 3 8230.715 9.3 554.85
m
N N N N N N 1 2 3 N 5 N 7 8 9 10 11 12 1 2
-30
-20
-10
0
10
20
30
Sample Number
% D
evia
tion
>=
<=
-30
-20
-10
0
10
20
30
% D
evia
tion
>=
<=
500 2500 4500 6500 8500 10500
Concentration
Page 10Issue No: 1 Issue Date: 03/03/2016
Exc.
46
19
Page 11
All Methods
Abbott Architect Chemiluminescence
N Mean CV% U SDPA
1625 306.929 17.6 1.67 26.31
280 396.617 5.9 1.75 34.00
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
389.470 -0.21
0.23
396.617 120
102
Ferritin, ng/ml
%DEV
RM%DEV
-1.8
2.0
m
< 165.32 205.78 246.24 286.70 327.15 367.61 408.07 448.53 >
0
50
100
150
200
250
300
350
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
351.7
48
M
110.2
58
M
13.4
47
M
233.3
25
M
180.6
66
M
359.6
70
M
113.2
40
M
13.7
43
M
192.2
60
M
65.5
88
M
233.2
33
M
122.2
27
M
396.6
17
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 14.1%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
16.9%
14.10%RIQAS
Method N Mean CV% U
Roche Modular E170 / Cobas e601/e602 316 313.829 4.3 0.94
Abbott Architect Chemiluminescence 280 396.617 5.9 1.75
Roche Elecsys / Cobas e411 238 311.561 7.9 2.00
Siemens Centaur XP/XPT/Classic 177 319.816 7.6 2.28
Beckman DxI 600 / 800 129 229.590 6.7 1.69
Beckman Access/LXi725 48 234.346 4.7 1.97
bioMerieux, VIDAS 38 288.153 9.2 5.39
Roche Cobas C501/502/701 41 275.650 10.3 5.56
Siemens/DPC Immulite 2000/2500 34 293.412 5.5 3.47
Ortho Vitros 3600/5600/ECi 36 214.229 4.9 2.16
Tosoh 30 226.890 4.4 2.28
Roche Cobas 4000/c311 26 307.635 7.8 5.89
Diasorin, Liaison 22 327.400 5.4 4.71
Siemens Centaur CP 23 307.636 6.0 4.82
Beckman AU400/600/640/2700/5400 18 279.091 3.4 2.81
Siemens/DPC Immulite 1000 21 261.905 7.4 5.25
Siemens Dimension 15 289.189 4.1 3.79
Fujirebio Lumipulse G 10 215.930 2.4 2.03
Roche Integra 10 298.175 5.5 6.54
Immunotech IRMA 6 288.418 6.9 10.16
Roche Tinaquant 5 276.480 5.5 8.56
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 50 100 150 200 250 300 350 400
Concentration
Page 11Issue No: 1 Issue Date: 03/03/2016
Exc.
70
26
Page 12
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
878 13.232 16.6 0.09 1.58
183 14.174 5.3 0.07 1.69
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
12.780 -0.83
6.98
14.174 80
91
Folate, ng/ml
%DEV
RM%DEV
-9.8
88.5
m
< 7.46 9.11 10.76 12.40 14.05 15.70 17.34 18.99 >
0
20
40
60
80
100
120
140
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
29.6
09
M
16.0
73
M
4.3
20
M
9.8
25
M
8.2
45
M
16.5
52
M
9.0
58
M
4.1
49
M
10.2
22
M
6.4
37
M
12.4
23
M
10.5
72
M
14.1
74
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 19.6%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
39%
19.60%RIQAS
Method N Mean CV% U
Abbott Architect 194 11.337 6.6 0.07
Roche Cobas 6000/8000 183 14.174 5.3 0.07
Roche Cobas 4000/e411 121 14.049 10.3 0.17
Siemens Centaur XP/XPT/Classic(enhanced) 81 21.716 12.0 0.36
Beckman DxI 600 / 800 - A98032 61 12.527 4.8 0.10
Beckman DxI 600 / 800 - A14208 53 12.482 4.2 0.09
Siemens/DPC Immulite 2000 43 12.526 17.1 0.41
Roche Elecsys 37 14.680 8.5 0.26
Roche Modular E170 35 14.327 5.0 0.15
Beckman Access/LXi725 24 12.309 3.4 0.11
Ortho Vitros 3600/5600/ECi 17 7.281 9.7 0.21
TOSOH 8 14.558 6.7 0.43
Siemens Dimension 7 6.113 11.0 0.32
MP Biomedicals RIA 6 11.860 18.2 1.10
Siemens Centaur CP (enhanced kit) 3 23.555 3.1 0.53
SNIBE Maglumi Analyser 4 20.982 14.3 1.88
Abbott Axsym 1 15.000 0.0 0.00
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-40
-30
-20
-10
0
10
20
30
40
Sample Number
% D
evia
tion
>=
<=
-40
-30
-20
-10
0
10
20
30
40
% D
evia
tion
>=
<=
0 5 10 15 20 25 30
Concentration
Page 12Issue No: 1 Issue Date: 03/03/2016
Exc.
121
25
Page 13
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
1549 64.186 14.6 0.30 4.96
273 61.064 4.4 0.20 4.71
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
58.090 -0.63
-0.26
61.064 92
110
FSH, mU/ml
%DEV
RM%DEV
-4.9
-2.0
m
< 39.52 46.56 53.61 60.66 67.70 74.75 81.80 88.84 >
0
50
100
150
200
250
300
mU/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
45.5
61
M
23.1
36
M
6.5
85
M
34.5
46
M
25.4
01
M
55.5
04
M
27.6
29
M
5.8
49
M
30.5
77
M
16.5
68
M
40.5
66
M
27.4
00
M
61.0
64
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 12.7%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
21.19%
12.70%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 273 61.064 4.4 0.20
Abbott Architect 270 57.000 4.9 0.21
Roche Cobas 4000/e411 236 63.452 5.6 0.29
Siemens Centaur XP/XPT/Classic 164 90.357 4.6 0.40
Beckman DxI 600/800 114 67.735 4.7 0.37
bioMerieux, VIDAS 73 83.013 7.6 0.92
Roche Elecsys 71 63.625 6.6 0.62
Siemens/DPC Immulite 2000/2500 62 62.110 7.0 0.69
Beckman Access/LXi725 47 68.435 6.4 0.80
Tosoh 40 66.036 5.7 0.75
Roche Modular E170 39 60.481 3.9 0.47
Ortho Vitros 3600/5600/ECi 34 48.735 3.4 0.36
Siemens/DPC Immulite 1000 27 59.739 6.0 0.87
Diasorin, Liaison 21 77.087 7.8 1.63
Siemens Centaur CP 22 80.081 6.7 1.43
Fujirebio Lumipulse G 9 54.211 2.3 0.53
SNIBE Maglumi analysers 4 40.463 11.6 2.92
DIAsource, IRMA 3 61.137 2.0 0.87
Monobind Inc. ELISA/CLIA 3 54.900 13.0 5.15
MP Biomedicals IRMA 3 61.813 11.1 4.94
Immunotech IRMA 2 53.725 3.1 1.49
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
0 10 20 30 40 50 60
Concentration
Page 13Issue No: 1 Issue Date: 03/03/2016
Exc.
143
33
Page 14
All Methods
Roche hCG+Beta
N Mean CV% U SDPA
1880 411.652 21.3 2.53 34.79
747 426.792 5.4 1.05 36.07
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
434.400 0.21
0.09
426.792 120
100
hCG, mU/ml
%DEV
RM%DEV
1.8
0.8
m
< 181.36 247.16 312.95 378.75 444.54 510.34 576.14 641.93 >
0
50
100
150
200
250
300
350
400
450
mU/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
271.2
24
M
15.9
49
M
16.2
20
M
146.6
02
M
138.4
68
M
363.5
36
M
21.2
56
M
14.5
53
M
187.7
36
M
17.7
71
M
183.6
90
M
22.5
14
M
426.7
92
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 13.9%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
N/A
13.90%RIQAS
Method N Mean CV% U
Roche hCG+Beta 747 426.792 5.4 1.05
Abbott Architect 344 356.038 4.2 1.00
Siemens Centaur XP/XPT/Classic 176 351.865 4.4 1.45
Beckman DxI 600 / 800 100 341.324 5.1 2.16
bioMerieux, VIDAS 87 677.866 8.7 7.93
Siemens/DPC Immulite 2000 61 707.708 7.6 8.63
Roche hCG STAT(Intact) 53 617.272 7.0 7.40
Ortho Vitros 3600/5600/ECi 53 685.048 4.7 5.55
Beckman Access/LXi725 46 337.471 6.0 3.71
Siemens/DPC Immulite 1000 33 701.864 8.9 13.64
Siemens Centaur CP 28 355.909 7.0 5.89
Beckman Access Total BhCG (5th IS) 28 342.396 4.7 3.82
Beckman DXI Total BhCG (5th IS) 27 344.781 6.1 5.06
Diasorin, Liaison 25 346.257 9.1 7.92
Siemens Dimension 20 632.568 4.5 8.00
Tosoh 18 631.728 5.5 10.24
Fujirebio Lumipulse G 10 297.160 9.5 11.11
Roche Cobas Core EIA 8 425.475 4.6 8.71
SNIBE Maglumi analysers 5 517.265 14.7 42.48
Radiometer AQT90 Flex 4 333.250 4.4 9.08
Boditech Med Inc i-CHROMA 2 668.050 4.6 27.06
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 50 100 150 200 250 300 350 400
Concentration
Page 14Issue No: 1 Issue Date: 03/03/2016
Exc.
186
74
Page 15
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
739 444.085 9.7 1.98 37.53
131 457.909 3.6 1.79 38.70
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
465.000 0.18
0.02
457.909 120
117
IgE, U/ml
%DEV
RM%DEV
1.5
0.2
m
< 331.32 363.54 395.76 427.97 460.19 492.40 524.62 556.84 >
0
20
40
60
80
100
120
140
U/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
427.4
32
M
144.2
40
M
225.2
91
M
288.9
61
M
324.5
55
M
495.0
72
M
137.3
11
M
238.0
26
M
365.1
70
M
190.5
78
M
309.4
59
M
112.3
69
M
457.9
09
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 13.9%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
N/A
13.90%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 131 457.909 3.6 1.79
Roche Cobas 4000/e411 119 460.466 5.7 3.02
Siemens/DPC Immulite 2000/2500 87 461.962 8.0 4.97
Siemens Centaur XP/XPT/Classic 73 390.017 7.0 3.99
bioMerieux, VIDAS 46 413.164 10.2 7.79
Beckman DxI 600 / 800 47 403.107 7.7 5.66
Abbott Architect ci8200 34 504.277 2.9 3.17
Siemens/DPC Immulite 1000 29 467.966 7.2 7.80
Roche Elecsys 29 450.766 5.5 5.77
TOSOH 29 444.387 7.7 7.96
Phadia Immunocap instruments 17 387.235 7.9 9.28
Roche Modular E170 14 458.941 2.9 4.51
Beckman Access/LXi725 12 419.304 10.1 15.24
Siemens Centaur CP 8 408.738 4.5 8.17
Fujirebio Lumipulse G 9 387.671 4.0 6.45
Randox RX series Instruments 6 528.887 14.5 39.14
ELISA 5 391.940 16.9 36.95
Siemens/Dade Behring Nephelometer 4 459.500 3.9 11.21
Monobind Inc. ELISA / CLIA 5 441.234 14.7 36.25
SNIBE Maglumi analysers 4 423.305 28.0 74.08
Beckman Immage 2 422.360 23.7 88.30
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
50 150 250 350 450 550
Concentration
Page 15Issue No: 1 Issue Date: 03/03/2016
Exc.
54
16
Page 16
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
721 25.209 13.7 0.16 2.99
152 26.063 4.0 0.11 3.09
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
25.810 -0.08
0.04
26.063 120
Too Few
Insulin, uU/ml
%DEV
RM%DEV
-1.0
0.5
m
< 16.14 18.73 21.32 23.91 26.50 29.09 31.68 34.27 >
0
20
40
60
80
100
120
uU/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
26.9
18
M
8.5
97
M
2.0
99
M
17.8
72
M
14.3
26
M
25.0
18
M
9.1
34
M
0.8
68
M
13.2
95
M
5.0
12
M
16.9
07
M
6.9
25
M
26.0
63
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 19.5%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
32.9%
19.50%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 152 26.063 4.0 0.11
Abbott Architect 141 22.081 5.1 0.12
Roche Cobas 4000/e411 104 25.559 6.0 0.19
Siemens Centaur XP/XPT/Classic 79 30.193 7.3 0.31
Beckman DxI 600 / 800 66 23.016 5.4 0.19
Siemens/DPC Immulite 2000 28 10.035 17.3 0.41
Roche Elecsys 27 25.490 6.6 0.41
Tosoh 24 35.531 6.4 0.58
Roche Modular E170 23 25.567 3.8 0.25
Beckman Access/LXi725 21 23.340 8.4 0.54
Siemens/DPC Immulite 1000 20 9.383 16.2 0.42
DiaSorin, Liaison 16 26.470 11.2 0.93
Fujirebio Lumipulse G 8 25.225 3.5 0.39
Siemens Centaur CP 6 31.723 6.0 0.97
SNIBE Maglumi analysers 4 19.881 14.1 1.76
CIS, RIA coated tube 3 29.117 14.9 3.12
Diasource IRMA 2 32.855 3.6 1.06
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-30
-20
-10
0
10
20
30
Sample Number
% D
evia
tion
>=
<=
-30
-20
-10
0
10
20
30
% D
evia
tion
>=
<=
0 5 10 15 20 25
Concentration
Page 16Issue No: 1 Issue Date: 03/03/2016
Exc.
81
10
Page 17
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
1555 43.342 11.9 0.16 3.16
280 45.401 3.8 0.13 3.31
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
43.620 -0.54
-0.47
45.401 99
104
LH, mU/ml
%DEV
RM%DEV
-3.9
-3.4
m
< 29.75 33.63 37.51 41.39 45.28 49.16 53.04 56.93 >
0
50
100
150
200
250
300
mU/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
62.5
27
M
38.2
39
M
4.3
70
M
49.9
22
M
32.8
17
M
48.2
84
M
30.8
56
M
3.1
45
M
26.6
73
M
17.4
75
M
39.6
22
M
29.6
28
M
45.4
01
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 12%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
27.92%
12.00%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 280 45.401 3.8 0.13
Abbott Architect 264 38.637 6.1 0.18
Roche Cobas 4000/e411 232 45.780 4.8 0.18
Siemens Centaur XP/XPT/Classic 166 45.988 5.9 0.26
Beckman DxI 600 / 800 121 33.778 5.9 0.23
bioMerieux, VIDAS 73 43.876 4.3 0.28
Roche Elecsys 71 45.776 6.2 0.42
Siemens/DPC Immulite 2000 57 55.573 5.6 0.51
Beckman Access/LXi725 45 34.619 5.8 0.37
Roche Modular E170 40 44.949 3.8 0.34
Tosoh 36 42.980 3.3 0.30
Ortho Vitros 3600/5600/ECi 36 48.706 4.6 0.47
Siemens/DPC Immulite 1000 28 60.307 6.4 0.91
Diasorin, Liaison 24 56.562 6.6 0.96
Siemens Centaur CP 22 46.265 5.9 0.73
Fujirebio Lumipulse G 11 41.136 4.5 0.70
SNIBE Maglumi analysers 7 70.489 7.7 2.57
DIAsource, IRMA 4 31.310 5.9 1.15
Monobind Inc. ELISA/CLIA 3 54.817 24.9 9.85
Boditech Med Inc i-CHROMA 2 42.215 4.6 1.73
Siemens Dimension 2 49.600 1.1 0.50
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
0 10 20 30 40 50 60
Concentration
Page 17Issue No: 1 Issue Date: 03/03/2016
Exc.
126
27
Page 18
All Methods
Roche Cobas 6000/8000 (Estradiol III)
N Mean CV% U SDPA
1405 417.323 28.2 3.93 42.88
113 341.029 3.4 1.35 35.04
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
359.900 0.54
0.29
341.029 98
109
Oestradiol, pg/ml
%DEV
RM%DEV
5.5
3.0
m
< 108.01 196.38 284.76 373.13 461.50 549.88 638.25 726.63 >
0
50
100
150
200
250
300
pg/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
405.4
15
M
236.3
18
M
65.7
48
M
314.0
75
M
200.0
52
M
346.5
04
M
199.2
00
M
47.8
01
M
197.8
88
M
119.1
12
M
269.1
03
M
188.5
22
M
341.0
29
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 16.9%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
26.86%
16.90%RIQAS
Method N Mean CV% U
Abbott Architect 230 295.404 3.9 0.94
Roche Cobas 4000/e411 (Estradiol II) 158 374.495 15.6 5.80
Roche Cobas 6000/8000 (Estradiol II) 147 356.632 11.7 4.30
Roche Cobas 6000/8000 (Estradiol III) 113 341.029 3.4 1.35
Beckman DxI 600 / 800 106 495.095 9.2 5.56
Siemens Centaur XP/XPT/Classic (eE2) 87 574.899 5.4 4.18
bioMerieux, VIDAS 71 671.085 6.2 6.17
Roche Cobas 4000/e411 (Estradiol III) 60 340.285 4.4 2.40
Siemens/DPC Immulite 2000/2500 59 548.249 5.8 5.14
Roche Elecsys (Estradiol II) 55 380.657 16.3 10.44
Siemens Centaur XP/XPT/Classic 46 570.991 5.7 5.98
Beckman Access/LXi725 37 524.075 10.0 10.81
Siemens/DPC Immulite 1000 25 656.762 9.3 15.34
Ortho Vitros 3600/5600/ECi 25 519.612 5.1 6.62
Roche Modular E170 (Estradiol II) 21 363.396 10.9 10.76
Tosoh (E2) 16 438.971 4.2 5.73
Tosoh (iE2-hsE2) 15 426.047 6.6 9.05
Diasorin, LIAISON 16 253.531 8.9 7.04
Roche Modular E170 (Estradiol III) 13 345.186 3.7 4.46
Siemens Centaur XP/XPT/Classic (E26 III) 11 566.617 5.0 10.67
Siemens Centaur CP 11 639.895 5.8 14.03
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
20 70 120 170 220 270 320 370 420 470
Concentration
Page 18Issue No: 1 Issue Date: 03/03/2016
Exc.
74
10
Page 19
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
1293 37.414 17.0 0.22 4.14
234 41.930 5.3 0.18 4.64
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
46.280 0.94
0.19
41.930 74
108
Progesterone, ng/ml
%DEV
RM%DEV
10.4
2.2
m
< 20.72 25.49 30.26 35.03 39.79 44.56 49.33 54.10 >
0
20
40
60
80
100
120
140
160
180
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
40.9
36
M
10.1
10
M
0.7
20
M
25.2
82
M
21.2
97
M
44.1
77
M
9.7
52
M
0.9
74
M
21.9
88
M
5.1
79
M
24.6
56
M
9.7
29
M
41.9
30
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 18.2%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
N/A
18.20%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 234 41.930 5.3 0.18
Abbott Architect 208 34.190 6.9 0.20
Roche Cobas 4000/e411 194 42.320 6.1 0.23
Siemens Centaur XP/XPT/Classic 132 29.388 6.4 0.20
Beckman DXI Prog. Cal 33555 72 35.919 8.3 0.44
bioMerieux, VIDAS 70 50.104 6.3 0.47
Roche Elecsys 65 42.253 7.1 0.47
Siemens/DPC Immulite 2000/2500 57 27.130 9.7 0.44
Beckman Access Prog. Cal 33555 36 36.559 9.1 0.70
Roche Modular E170 35 41.338 3.9 0.34
Tosoh 24 42.367 19.0 2.06
Siemens/DPC Immulite 1000 26 31.046 6.8 0.52
Ortho Vitros 3600/5600/ECi 23 34.244 3.1 0.28
Siemens Centaur CP 17 29.827 9.2 0.83
Beckman DXI Prog.DE Cal. A80773 17 33.844 9.2 0.94
Diasorin Liaison 12 26.683 4.2 0.41
SNIBE Maglumi analysers 5 50.484 7.7 2.16
Immunotech RIA 3 32.788 10.9 2.59
Fujirebio Lumipulse G 2 34.060 1.8 0.54
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-30
-20
-10
0
10
20
30
Sample Number
% D
evia
tion
>=
<=
-30
-20
-10
0
10
20
30
% D
evia
tion
>=
<=
0 5 10 15 20 25 30 35 40
Concentration
Page 19Issue No: 1 Issue Date: 03/03/2016
Exc.
93
26
Page 20
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
1338 2553.050 22.2 19.34 366.31
235 2453.748 3.9 7.86 352.06
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
2457.080 0.01
-0.03
2453.748 120
118
Prolactin, uU/ml
%DEV
RM%DEV
0.1
-0.2
m
< 1067.17 1491.70 1916.24 2340.78 2765.31 3189.85 3614.39 4038.92 >
0
50
100
150
200
250
300
350
400
uU/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
1249.9
63
M
697.2
00
M
129.9
93
M
976.6
18
M
675.1
03
M
1210.0
00
M
796.7
73
M
136.2
17
M
679.7
83
M
466.3
83
M
1007.2
91
M
1405.5
55
M
2453.7
48
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 23.6%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
29.4%
23.60%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 235 2453.748 3.9 7.86
Roche Cobas 4000/e411 226 2492.871 6.3 12.96
Abbott Architect 213 2993.699 9.4 24.09
Siemens Centaur XP/XPT/Classic 155 2739.586 9.5 26.14
Beckman DxI 600 / 800 107 117.502 5.5 0.78
bioMerieux, VIDAS 61 2843.956 8.8 39.95
Siemens/DPC Immulite 2000/2500 54 1078.106 7.0 12.87
Roche Elecsys 53 2526.207 6.7 28.88
Abbott Architect (Re-standardised) 46 2886.132 6.0 31.96
Beckman Access/LXi725 40 118.633 4.7 1.10
Roche Elecsys/E170/Cobas 6000/8000 PRLII 42 2472.704 4.6 21.82
Tosoh 28 3408.069 13.7 110.54
Ortho Vitros 3600/5600/ECi 32 2396.299 5.7 30.03
Roche Modular E170 25 2433.509 3.1 18.60
Siemens/DPC Immulite 1000 25 1155.224 8.8 25.47
Diasorin, Liaison 22 252.026 6.8 4.60
Siemens Centaur CP 19 3010.362 10.7 92.10
Fujirebio Lumipulse G 7 719.161 2.6 8.86
Immunotech IRMA 10 229.560 4.2 3.82
SNIBE Maglumi analysers 6 4127.557 15.9 334.96
ELISA 3 3236.500 28.8 672.58
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-30
-20
-10
0
10
20
30
Sample Number
% D
evia
tion
>=
<=
-30
-20
-10
0
10
20
30
% D
evia
tion
>=
<=
0 500 1000 1500 2000 2500
Concentration
Page 20Issue No: 1 Issue Date: 03/03/2016
Exc.
321
37
Page 21
All Methods
Roche Elecsys
N Mean CV% U SDPA
907 21.469 12.0 0.11 1.53
39 21.015 6.6 0.28 1.49
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
20.380 -0.42
0.48
21.015 109
89
PSA, Free, ng/ml
%DEV
RM%DEV
-3.0
3.4
m
< 14.70 16.63 18.57 20.50 22.43 24.36 26.29 28.23 >
0
50
100
150
200
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
18.2
68
M
9.3
54
M
1.2
96
M
13.4
96
M
9.3
33
M
18.9
64
M
9.3
04
M
1.2
22
M
10.0
80
M
5.1
79
M
13.9
24
M
9.0
49
M
21.0
15
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 11.7%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
N/A
11.70%RIQAS
Method N Mean CV% U
Abbott Architect 210 23.764 8.1 0.17
Roche Cobas 6000/8000 203 20.891 3.8 0.07
Roche Cobas 4000/e411 111 21.550 5.5 0.14
Siemens Centaur XP/XPT/Classic 101 20.907 5.2 0.14
Beckman DXI standardised to Hybritech 60 26.825 17.2 0.74
Roche Elecsys 39 21.015 6.6 0.28
Siemens/DPC Immulite 2000/2500 37 18.785 7.1 0.28
BioMerieux VIDAS 15 37.296 12.6 1.52
Roche Modular E170 23 20.716 3.2 0.17
Beckman Access standardised to Hybritech 18 30.402 13.2 1.18
Diasorin, Liaison 18 12.273 5.4 0.20
Siemens/DPC Immulite 1000 16 17.554 6.4 0.35
TOSOH 11 19.424 4.6 0.33
Fujirebio Lumipulse G 14 17.853 2.7 0.16
Siemens Dimension 5 17.740 5.2 0.51
Ortho Vitros 3600/5600/ECi 4 17.530 0.6 0.06
CIS, RIA coated tube 4 17.403 5.3 0.58
Beckman DXI standard to WHO IRP96/670 4 22.605 12.2 1.72
Beckman Access standard to WHO IRP96/670 3 24.500 25.3 4.48
SNIBE Maglumi analysers 4 18.497 7.6 0.87
Ortho Vitros 3600/5600/ECi PSA II 4 16.600 7.0 0.73
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
0 5 10 15 20
Concentration
Page 21Issue No: 1 Issue Date: 03/03/2016
Exc.
146
5
Page 22
All Methods
Roche Elecsys
N Mean CV% U SDPA
1860 33.454 14.2 0.14 2.50
78 38.029 8.8 0.47 2.84
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
37.680 -0.12
0.02
38.029 120
98
PSA, Total, ng/ml
%DEV
RM%DEV
-0.9
0.1
m
< 20.95 24.52 28.09 31.66 35.23 38.81 42.38 45.95 >
0
50
100
150
200
250
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
25.6
39
M
13.1
49
M
1.8
47
M
19.8
65
M
13.5
32
M
31.6
93
M
15.7
17
M
1.9
85
M
17.0
27
M
8.7
44
M
23.6
50
M
15.7
31
M
38.0
29
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 12.3%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
33.6%
12.30%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 361 36.759 4.9 0.12
Abbott Architect 362 30.449 6.1 0.12
Roche Cobas 4000/e411 246 38.786 6.6 0.20
Siemens Centaur XP/XPT/Classic 193 29.484 6.5 0.17
Beckman DXI standardised to Hybritech 125 34.232 6.0 0.23
Roche Elecsys 78 38.029 8.8 0.47
Beckman Access standardised to Hybritech 56 33.753 5.6 0.32
Siemens Immulite 2000/2500, Total PSA 45 22.224 7.4 0.31
bioMerieux, Vidas TPSA 42 29.285 7.0 0.39
Roche Modular E170 38 36.168 3.8 0.28
Diasorin, Liaison 38 18.906 7.7 0.30
Ortho Vitros 3600/5600/ECi PSA II 38 36.310 3.9 0.29
Tosoh 33 20.250 8.4 0.37
Siemens Immulite 1000, Total PSA 30 21.833 5.9 0.29
Siemens Centaur CP 24 31.305 7.7 0.61
Beckman DXI standard to WHO IRP96/670 18 28.388 14.9 1.25
bioMerieux, Vidas 15 29.624 7.2 0.69
CIS, RIA coated tube 14 30.041 3.2 0.32
Fujirebio Lumipulse G 13 27.688 2.7 0.26
Beckman Access standard to WHO IRP96/670 15 33.902 5.2 0.57
Siemens Immulite 1000, 3rd gen 7 22.171 3.3 0.35
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
0 5 10 15 20 25 30 35
Concentration
Page 22Issue No: 1 Issue Date: 03/03/2016
Exc.
132
5
Page 23
All Methods
Roche Elecsys PTH (1-84)
N Mean CV% U SDPA
867 156.887 42.3 2.81 66.32
7 120.229 25.6 14.55 34.07a
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
120.700 0.01
0.71
120.229 N/A
N/A
Parathyroid hormone, pg/ml
%DEV
RM%DEV
0.4
11.8
m
< 22.24 66.72 111.20 155.68 200.16 244.64 289.12 333.60 >
0
20
40
60
80
100
120
140
160
pg/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
117.0
35
M
71.5
60
M
12.0
29
M
85.3
20
M
15.2
03
M
163.2
31
M
91.4
43
M
25.3
61
M
48.5
82
M
24.1
42
M
113.4
20
M
67.3
14
M
120.2
29
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
30.2%
N/A RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 PTH/PTH STAT 150 133.398 21.3 2.91
Abbott Architect 115 287.515 19.7 6.60
Roche Cobas 4000/e411 PTH/PTH STAT 107 137.174 28.6 4.73
Siemens Centaur XP/XPT/Classic 89 223.642 20.7 6.13
Beckman DxI 600 / 800 77 135.381 29.5 5.68
Siemens/DPC Immulite 2000 42 230.421 19.6 8.69
Roche Cobas 4000/e411 PTH (1-84) 41 139.884 22.9 6.24
Roche Elecsys PTH/PTH STAT 39 120.661 25.4 6.13
Roche Cobas 6000/8000 PTH (1-84) 34 127.864 20.8 5.69
DiaSorin, Liaison 1-84 PTH 21 76.985 32.2 6.76
Roche Modular E170 PTH/PTH STAT 22 111.366 27.9 8.28
Beckman Access/LXi725 22 130.629 20.8 7.26
Tosoh 18 190.357 27.0 15.13
Siemens/DPC Immulite 1000 21 186.208 24.2 12.27
Ortho Vitros 3600/5600/ECi 12 231.233 26.1 21.74
DiaSorin, Liaison N-TACT PTH II 6 221.000 24.8 27.93
Roche Modular E170 PTH (1-84) 7 123.671 2.9 1.71
CIS IRMA 7 171.348 25.8 20.91
Roche Elecsys PTH (1-84) 7 120.229 25.6 14.55
Siemens Centaur CP 5 225.400 30.5 38.39
Scantibodies, RIA 3 46.100 73.3 24.39
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-30
-20
-10
0
10
20
30
Sample Number
% D
evia
tion
>=
<=
-30
-20
-10
0
10
20
30
% D
evia
tion
>=
<=
0 20 40 60 80 100 120 140 160
Concentration
Page 23Issue No: 1 Issue Date: 03/03/2016
Exc.
78
0
Page 24
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
1665 29.896 14.3 0.13 2.58
341 33.266 2.9 0.07 2.87
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
33.550 0.10
0.04
33.266 120
119
Free T3, pmol/l
%DEV
RM%DEV
0.9
0.4
m
< 18.65 21.86 25.07 28.29 31.50 34.71 37.92 41.13 >
0
50
100
150
200
250
300
pmol/l
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
34.1
31
M
19.7
54
M
4.9
35
M
27.6
14
M
19.7
36
M
34.0
51
M
18.9
28
M
5.3
31
M
20.1
38
M
11.7
09
M
26.2
16
M
18.0
10
M
33.2
66
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 14.2%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
11.3%
14.20%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 341 33.266 2.9 0.07
Abbott Architect 318 28.438 11.6 0.23
Roche Cobas 4000/e411 226 33.210 3.7 0.10
Siemens Centaur XP/XPT/Classic 185 27.446 6.7 0.17
Beckman DxI 600 / 800 136 24.050 5.8 0.15
Roche Elecsys 83 32.946 4.2 0.19
Beckman Access/LXi725 62 24.796 9.5 0.37
BioMerieux VIDAS 52 26.653 6.2 0.29
Siemens/DPC Immulite 2000/2500 40 19.906 4.6 0.18
Diasorin, Liaison 18 44.878 7.9 1.04
Roche Modular E170 36 33.237 2.4 0.17
Tosoh 26 43.873 17.9 1.92
Ortho Vitros 3600/5600/ECi 17 35.002 0.1 0.01
Siemens Centaur CP 30 27.307 8.1 0.50
Siemens/DPC Immulite 1000 17 19.345 10.8 0.63
Fujirebio Lumipulse G 11 34.991 4.1 0.54
SNIBE Maglumi analysers 6 33.649 20.2 3.47
Siemens Dimension Vista LOCI 4 37.386 1.2 0.27
Brahms, RIA 3 44.211 36.2 11.55
Siemens Dimension Exl LOCI 3 37.814 2.4 0.65
Diasorin (RIA) 1 26.260 0.0 0.00
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 5 10 15 20 25 30 35
Concentration
Page 24Issue No: 1 Issue Date: 03/03/2016
Exc.
180
41
Page 25
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
753 4.494 13.6 0.03 0.41
135 4.712 5.6 0.03 0.43
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
4.360 -0.81
0.15
4.712 81
105
Total T3, ng/ml
%DEV
RM%DEV
-7.5
1.4
m
< 2.89 3.34 3.80 4.26 4.72 5.18 5.63 6.09 >
0
20
40
60
80
100
120
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
4.6
05
M
3.0
47
M
1.0
43
M
3.8
77
M
2.8
85
M
4.5
20
M
2.9
29
M
1.1
18
M
2.8
84
M
1.9
91
M
3.7
01
M
2.9
88
M
4.7
12
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 15.1%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
9.22%
15.10%RIQAS
Method N Mean CV% U
Abbott Architect 174 3.821 6.3 0.02
Roche Cobas 6000/8000 135 4.712 5.6 0.03
Roche Cobas 4000/e411 90 4.775 6.7 0.04
Siemens Centaur XP/XPT/Classic 73 5.731 11.7 0.10
Siemens/DPC Immulite 2000/2500 39 4.687 6.6 0.06
Beckman DxI600 / 800 31 4.078 4.6 0.04
Ortho Vitros 3600/5600/ECi 29 5.138 5.1 0.06
bioMerieux, VIDAS 33 4.269 5.1 0.05
Roche Elecsys 26 4.758 7.5 0.09
Roche Modular E170 19 4.811 4.7 0.06
Beckman Access/LXi725 17 4.144 6.1 0.08
Siemens/DPC Immulite 1000 15 4.792 7.7 0.12
Siemens Centaur CP 13 6.403 7.7 0.17
CIS, RIA coated tube 12 3.132 7.5 0.08
Immunotech RIA 10 3.556 7.0 0.10
Diasorin, Liaison 8 4.341 9.9 0.19
Tosoh 7 4.866 3.6 0.08
SNIBE Maglumi analysers 6 6.082 22.7 0.70
Monobind Inc. ELISA 4 4.448 6.1 0.17
ELISA 2 3.600 42.4 1.35
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 1 2 3 4 5
Concentration
Page 25Issue No: 1 Issue Date: 03/03/2016
Exc.
70
15
Page 26
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
2140 71.957 20.5 0.40 5.47
427 86.727 6.9 0.36 6.59
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
91.790 0.77
0.07
86.727 83
112
Free T4, pmol/l
%DEV
RM%DEV
5.8
0.5
m
< 33.31 44.35 55.39 66.43 77.47 88.51 99.55 110.59 >
0
50
100
150
200
250
300
350
pmol/l
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
76.7
84
M
40.8
61
M
18.2
47
M
56.1
27
M
43.0
54
M
78.2
93
M
39.8
49
M
17.3
53
M
45.3
75
M
29.5
33
M
54.6
51
M
42.1
12
M
86.7
27
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 12.5%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
8%
12.50%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 427 86.727 6.9 0.36
Abbott Architect 384 58.382 11.6 0.43
Roche Cobas 4000/e411 291 83.137 7.1 0.43
Siemens Centaur XP/XPT/Classic 232 55.527 5.6 0.26
Beckman DxI 600 / 800 161 59.984 3.8 0.22
Roche Elecsys 95 82.389 7.3 0.78
Beckman Access/LXi725 78 56.128 5.7 0.45
bioMerieux, VIDAS-FT4N Kit 53 84.892 4.3 0.63
Siemens/DPC Immulite 2000/2500 45 74.745 2.9 0.40
Ortho Vitros 3600/5600/ECi 26 89.811 0.2 0.05
Tosoh 40 77.634 6.9 1.05
Roche Modular E170 40 86.821 5.5 0.94
Diasorin, Liaison 31 113.209 7.1 1.81
Siemens Centaur CP 39 61.155 5.5 0.68
Siemens/DPC Immulite 1000 26 74.966 3.6 0.65
CIS, RIA coated tube 12 62.484 8.3 1.87
Fujirebio Lumipulse G 9 71.080 3.9 1.15
Immunotech IRMA 8 52.346 5.4 1.24
Monobind Inc. ELISA / CLIA 8 45.083 24.0 4.78
SNIBE Maglumi analysers 5 87.626 7.8 3.83
Siemens Dimension Vista LOCI 4 98.690 2.3 1.44
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
0 10 20 30 40 50 60 70 80 90
Concentration
Page 26Issue No: 1 Issue Date: 03/03/2016
Exc.
148
30
Page 27
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
733 16.091 10.5 0.08 1.39
126 14.823 5.3 0.09 1.28
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
14.190 -0.49
0.22
14.823 102
105
Total T4, ug/dl
%DEV
RM%DEV
-4.3
1.9
m
< 11.63 12.91 14.18 15.45 16.72 17.99 19.27 20.54 >
0
20
40
60
80
100
ug/dl
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
13.8
07
M
10.1
89
M
4.2
77
M
11.9
86
M
8.9
94
M
13.9
78
M
10.0
38
M
3.4
33
M
8.7
38
M
6.7
48
M
11.9
63
M
10.6
26
M
14.8
23
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 14.2%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
7%
14.20%RIQAS
Method N Mean CV% U
Abbott Architect 166 16.959 6.7 0.11
Roche Cobas 6000/8000 126 14.823 5.3 0.09
Roche Cobas 4000/e411 83 14.634 5.4 0.11
Siemens Centaur XP/XPT/Classic 74 16.757 7.3 0.18
Siemens/DPC Immulite 2000/2500 48 15.798 6.9 0.20
Ortho Vitros 3600/5600/ECi 32 18.150 5.3 0.21
bioMerieux, VIDAS 32 19.299 6.7 0.28
Roche Elecsys 27 14.770 8.3 0.30
Beckman DxI 600 / 800 26 17.810 6.5 0.28
Roche Modular E170 17 14.321 3.2 0.14
Siemens/DPC Immulite 1000 15 16.867 8.2 0.45
Siemens Centaur CP 13 17.346 8.0 0.48
Beckman Access/LXi725 10 17.186 5.3 0.36
CIS, RIA coated tube 9 14.892 6.0 0.37
Immunotech RIA 8 12.606 5.8 0.32
Diasorin, Liaison 7 14.836 12.8 0.90
Tosoh 6 14.917 4.9 0.37
SNIBE Maglumi analysers 6 22.094 13.9 1.57
Monobind Inc. ELISA / CLIA 4 15.815 25.8 2.55
MP Biomedicals RIA 2 15.410 14.0 1.91
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 2 4 6 8 10 12 14 16
Concentration
Page 27Issue No: 1 Issue Date: 03/03/2016
Exc.
48
9
Page 28
All Methods
Roche Cobas 6000/8000 Test II
N Mean CV% U SDPA
1198 8.272 12.9 0.04 1.00
226 8.819 4.9 0.04 1.07
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
8.050 -0.72
0.13
8.819 86
104
Testosterone, ng/ml
%DEV
RM%DEV
-8.7
1.6
m
< 5.46 6.26 7.06 7.87 8.67 9.47 10.27 11.08 >
0
20
40
60
80
100
120
140
160
180
200
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
7.8
73
M
3.6
12
M
0.4
82
M
5.8
59
M
4.1
71
M
8.1
94
M
3.7
62
M
0.8
73
M
4.5
99
M
2.3
11
M
5.8
21
M
3.9
18
M
8.8
19
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 19.9%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
13.61%
19.90%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 Test II 226 8.819 4.9 0.04
Roche Cobas 4000/e411 Test II 187 8.728 6.3 0.05
Abbott Architect 142 8.228 6.8 0.06
Siemens Centaur XP/XPT/Classic 124 7.556 10.8 0.09
Beckman DxI 600 / 800 97 6.671 4.7 0.04
Roche Elecsys Test II 63 8.635 5.7 0.08
Abbott Architect 2nd gen 56 8.228 5.7 0.08
Siemens/DPC Immulite 2000/2500 54 11.030 8.8 0.17
bioMerieux VIDAS Testosterone II 47 7.103 8.9 0.12
Beckman Access/LXi725 38 7.636 7.3 0.11
Roche Modular E170 Test II 32 8.989 3.7 0.07
bioMerieux, VIDAS 28 7.134 7.0 0.12
TOSOH 20 11.646 6.7 0.22
Ortho Vitros 3600/5600/ECi 21 11.267 3.9 0.12
Siemens/DPC Immulite 1000 13 14.507 8.8 0.44
Diasorin, Liaison 12 4.502 21.7 0.35
Siemens Centaur CP 9 7.939 10.2 0.34
SNIBE Maglumi analysers 7 9.584 17.2 0.78
CIS, RIA Coated tube 5 7.456 6.3 0.26
Fujirebio Lumipulse G 5 8.986 5.0 0.25
Diasorin, RIA-mat 2 5.310 8.3 0.39
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-30
-20
-10
0
10
20
30
Sample Number
% D
evia
tion
>=
<=
-30
-20
-10
0
10
20
30
% D
evia
tion
>=
<=
0 1 2 3 4 5 6 7 8 9
Concentration
Page 28Issue No: 1 Issue Date: 03/03/2016
Exc.
133
22
Page 29
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
2231 21.675 8.9 0.05 1.63
424 22.008 2.9 0.04 1.66
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
22.410 0.24
0.05
22.008 120
120
TSH, uU/ml
%DEV
RM%DEV
1.8
0.4
m
< 16.62 18.06 19.51 20.95 22.39 23.83 25.28 26.72 >
0
50
100
150
200
250
300
350
400
uU/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
15.7
32
M
2.4
10
M
0.1
75
M
7.6
85
M
6.5
39
M
19.9
58
M
2.6
51
M
0.1
68
M
7.4
28
M
1.4
46
M
8.0
30
M
2.4
24
M
22.0
08
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 12.4%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
23.7%
12.40%RIQAS
Method N Mean CV% U
Roche Cobas 6000/8000 424 22.008 2.9 0.04
Abbott Architect 411 19.123 4.2 0.05
Roche Cobas 4000/e411 324 22.336 3.8 0.06
Siemens Centaur XP/Classic TSH3-Ultra 124 23.393 4.4 0.12
Roche Elecsys 97 22.148 4.6 0.13
Siemens Centaur XP/XPT/Classic 95 23.593 5.6 0.17
Beckman DxI600/800 Hyper TSH 93 21.489 7.7 0.22
Access/LXi725 hyper TSH 3rd gen 65 21.185 7.5 0.25
Siemens/DPC Immulite 2000/2500 66 21.760 6.9 0.23
Ortho Vitros 3600/5600/ECi 59 30.489 3.9 0.19
Beckman DxI600/800 Fast TSH 57 20.225 6.9 0.23
bioMerieux, VIDAS, TSH 52 23.434 7.2 0.29
Tosoh 45 23.639 7.5 0.33
Siemens/DPC Immulite 1000 45 22.029 5.8 0.24
Diasorin, Liaison 42 26.979 6.9 0.36
Roche Modular E170 39 22.012 2.5 0.11
Siemens Centaur CP TSH3-Ultra 23 23.756 5.6 0.34
Siemens Centaur CP 21 23.982 8.3 0.54
CIS, IRMA 18 24.676 5.4 0.40
Siemens Centaur XP/Classic 3rdGeneration 16 23.799 3.5 0.26
Beckman DxI600/800 1st gen. 17 21.730 10.9 0.72
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
0 5 10 15 20
Concentration
Page 29Issue No: 1 Issue Date: 03/03/2016
Exc.
196
44
Page 30
All Methods
Roche Integra
N Mean CV% U SDPA
317 138.657 6.3 0.61 10.96
21 136.873 3.9 1.46 10.82
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
136.440 -0.04
-0.11
136.873 120
115
Valproic acid, ug/ml
%DEV
RM%DEV
-0.3
-0.9
m
< 115.80 122.33 128.86 135.39 141.92 148.45 154.98 161.51 >
0
10
20
30
40
50
60
ug/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
133.9
41
M
77.6
38
M
28.5
70
M
108.0
92
M
80.5
85
M
137.0
01
M
78.4
44
M
29.8
01
M
84.0
25
M
54.3
84
M
107.9
17
M
79.2
32
M
136.8
73
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 13%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
N/A
13.00%RIQAS
Method N Mean CV% U
Abbott Architect 108 137.664 5.4 0.90
Roche Cobas 6000/8000 51 144.743 4.9 1.25
Siemens Centaur XP/XPT/Classic 27 134.355 5.7 1.83
Siemens/DPC Immulite 2000/2500 25 140.683 4.2 1.47
Roche Integra 21 136.873 3.9 1.46
Siemens Dimension 16 135.632 4.8 2.05
Siemens/DPC Immulite 1000 14 141.871 6.3 2.96
Beckman DxC 10 107.835 2.7 1.15
Beckman AU400/600/640/2700/5400 11 140.145 8.5 4.49
Ortho Vitros 4600/5600/5.1 7 136.319 2.6 1.67
Siemens Advia 1200/1650/1800/2400 5 136.820 9.1 6.95
Roche Cobas 4000/c311 5 144.986 4.9 4.00
Abbott Axsym 4 124.060 13.9 10.82
Siemens Syva/Emit 2 150.800 1.1 1.50
Siemens Centaur CP 2 144.245 3.6 4.56
Roche Modular P/D 2 140.450 5.3 6.56
Randox RX Series 2 136.665 2.2 2.67
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-15
-10
-5
0
5
10
15
Sample Number
% D
evia
tion
>=
<=
-15
-10
-5
0
5
10
15
% D
evia
tion
>=
<=
10 30 50 70 90 110 130 150
Concentration
Page 30Issue No: 1 Issue Date: 03/03/2016
Exc.
38
3
Page 31
All Methods
Roche Cobas 6000/8000
N Mean CV% U SDPA
1135 884.944 9.0 2.95 96.84
212 928.956 4.5 3.60 101.66
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
936.200 0.07
0.36
928.956 120
102
Vitamin B12, pg/ml
%DEV
RM%DEV
0.8
3.9
m
< 676.48 736.04 795.60 855.16 914.72 974.28 1033.84 1093.40 >
0
20
40
60
80
100
120
140
160
180
pg/ml
Num
ber o
f L
aborato
rie
s
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
951.8
27
M
573.7
62
M
166.8
25
M
1092.5
39
M
535.1
61
M
1022.9
10
M
555.6
85
M
149.0
62
M
571.0
13
M
340.5
78
M
1071.2
69
M
530.5
44
M
928.9
56
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 18%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
30%
18.00%RIQAS
Method N Mean CV% U
Abbott Architect 230 876.327 7.2 5.21
Roche Cobas 6000/8000 212 928.956 4.5 3.60
Roche Cobas 4000/e411 171 913.334 7.6 6.68
Siemens Centaur XP/XPT/Classic 132 878.895 6.2 5.92
Beckman DxI 600 / 800 118 751.788 8.5 7.36
Roche Elecsys 50 909.576 6.7 10.78
Siemens/DPC Immulite 2000 44 839.621 11.2 17.78
Roche Modular E170 38 927.735 3.9 7.28
Beckman Access/LXi725 32 830.165 7.7 14.16
Ortho Vitros 3600/5600/ECi 27 862.320 5.7 11.76
TOSOH 11 1127.602 7.8 33.30
Siemens Centaur CP 11 885.000 9.6 31.97
Roche Cobas 6000/8000 Gen II 9 949.705 9.3 36.92
Roche Cobas 4000/e411 Gen II 7 879.200 4.9 20.44
Siemens Dimension 5 829.613 2.1 9.69
Siemens/DPC Immulite 1000 5 735.572 38.3 157.29
MP Biomedicals RIA 5 993.798 4.2 23.35
SNIBE Maglumi analysers 5 803.930 5.0 22.35
Abbott Axsym 3 868.013 7.6 47.74
m
N N N N N N 1 2 3 4 5 N 7 8 9 10 11 12 1 2
-20
-15
-10
-5
0
5
10
15
20
Sample Number
% D
evia
tion
>=
<=
-20
-15
-10
-5
0
5
10
15
20
% D
evia
tion
>=
<=
0 200 400 600 800 1000
Concentration
Page 31Issue No: 1 Issue Date: 03/03/2016
Exc.
105
24
Page 32
All Methods
Roche Vitamin D Total
N Mean CV% U SDPA
643 30.400 16.7 0.25 5.58
251 26.745 12.1 0.26 4.91
Your Result SDI
RMSDI
Mean for Comparison TS
RMTS
26.480 -0.05
-0.33
26.745 120
96
25-OH-Vitamin D, ng/ml
%DEV
RM%DEV
-1.0
-6.1
m
< 17.06 20.87 24.68 28.49 32.30 36.11 39.92 43.73 >
0
20
40
60
80
100
ng/ml
Num
ber o
f L
aborato
rie
s
N N N N N N N 2 3 4 5 N 7 8 9 10 11 12 1 2
-1
0
1
Sample Number
Sta
ndar
d D
evia
tion
M
17.4
03
M
3.9
02
M
22.1
41
M
13.9
43
M
24.0
51
M
15.8
43
M
6.4
20
M
15.1
71
M
11.0
09
M
19.5
96
M
17.5
64
M
26.7
45
<-3
-2
-1
0
+1
+2
>+3
Mean for Comparison
N N N N N N N 2 3 4 5 N 7 8 9 10 11 12 1 2
0
10
20
30
40
50
60
70
80
90
100
110
120
Sample Number
Tar
get
Sco
re
TDPA = 30.2%
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
RIQAS ABC
Acceptable limits derived from Biological Variation
Acceptable limits of performance for
N/A
30.20%RIQAS
Method N Mean CV% U
Roche Vitamin D Total 251 26.745 12.1 0.26
Abbott Architect 149 31.975 7.5 0.24
Diasorin, Liaison 60 33.811 8.2 0.45
Siemens Centaur XP/XPT/Classic 51 48.341 7.9 0.67
bioMerieux Vidas/mini Vidas/Vidas 3 47 34.252 4.4 0.28
Beckman DxI 600 /800 30 25.863 7.8 0.46
Ortho Vitros 3600/5600/ECi 18 37.028 7.1 0.78
Fujirebio Lumipulse G 10 34.760 2.9 0.40
TOSOH 7 35.535 5.3 0.88
Beckman Access 25 OH Vitamin D Total 6 28.590 8.8 1.28
IDS iSYS 5 29.642 12.6 2.09
SNIBE Maglumi Analyser 3 57.238 16.3 6.72
HPLC/UPLC 3 36.774 25.5 6.77
Diasorin, RIA 2 35.800 8.7 2.75
DIAsource, RIA 2 27.580 50.4 12.27
DRG ELISA 2 28.700 11.8 3.00
m
N N N N N N N 2 3 4 5 N 7 8 9 10 11 12 1 2
-40
-30
-20
-10
0
10
20
30
40
Sample Number
% D
evia
tion
>=
<=
-40
-30
-20
-10
0
10
20
30
40
% D
evia
tion
>=
<=
0 5 10 15 20 25
Concentration
Page 32Issue No: 1 Issue Date: 03/03/2016
Exc.
69
20
Page 33
MONTHLY IMMUNOASSAY LABORATORY REF. NO. 152562/E CYCLE 14 SAMPLE 2 29/02/2016
Analyte
Mean for
Comparison
Your
Result SDI RMSDI %DEV RM%DEV TS RMTS Performance
AFP 241.201 254.800 0.61 -1.14 5.6 -11.0 93 84
CA 125 222.157 217.600 -0.26 0.00 -2.1 0.0 120 106
CA 15-3 87.443 95.560 1.08 -0.18 9.3 -1.6 68 94
CA 19-9 147.719 148.100 0.03 -0.02 0.3 -0.2 120 97
Carbamazepine 18.203 17.480 -0.47 0.04 -4.0 0.4 104 108
CEA 48.266 47.860 -0.10 0.17 -0.8 1.3 120 100
Cortisol 33.048 28.120 -1.67 -0.47 -14.9 -4.3 49 91
C-Peptide 4.214 4.780 0.73 0.03 13.4 0.6 85 107
DHEA-S 9408.440 9332.000 -0.07 0.03 -0.8 0.4 120 118
Ferritin 396.617 389.470 -0.21 0.23 -1.8 2.0 120 102
Folate 14.174 12.780 -0.83 6.98 -9.8 88.5 80 91
FSH 61.064 58.090 -0.63 -0.26 -4.9 -2.0 92 110
hCG 426.792 434.400 0.21 0.09 1.8 0.8 120 100
IgE 457.909 465.000 0.18 0.02 1.5 0.2 120 117
Insulin 26.063 25.810 -0.08 0.04 -1.0 0.5 120 Too Few
LH 45.401 43.620 -0.54 -0.47 -3.9 -3.4 99 104
Oestradiol 341.029 359.900 0.54 0.29 5.5 3.0 98 109
Progesterone 41.930 46.280 0.94 0.19 10.4 2.2 74 108
Prolactin 2453.748 2457.080 0.01 -0.03 0.1 -0.2 120 118
PSA, Free 21.015 20.380 -0.42 0.48 -3.0 3.4 109 89
PSA, Total 38.029 37.680 -0.12 0.02 -0.9 0.1 120 98
Parathyroid hormone 120.229 120.700 0.01 0.71 0.4 11.8 N/A N/A
Free T3 33.266 33.550 0.10 0.04 0.9 0.4 120 119
Total T3 4.712 4.360 -0.81 0.15 -7.5 1.4 81 105
Free T4 86.727 91.790 0.77 0.07 5.8 0.5 83 112
Total T4 14.823 14.190 -0.49 0.22 -4.3 1.9 102 105
Testosterone 8.819 8.050 -0.72 0.13 -8.7 1.6 86 104
TSH 22.008 22.410 0.24 0.05 1.8 0.4 120 120
Valproic acid 136.873 136.440 -0.04 -0.11 -0.3 -0.9 120 115
Vitamin B12 928.956 936.200 0.07 0.36 0.8 3.9 120 102
25-OH-Vitamin D 26.745 26.480 -0.05 -0.33 -1.0 -6.1 120 96
ORMSDI 0.24 ORM%DEV 3.1 ORMTS 104
RIQAS ABCPage 33
END OF REPORT
Issue No: 1 Issue Date: 03/03/2016
![MAGLUMI 2019-nCoV lgG/lgM CLIA Assays · MAGLUMI® 2019-nCoV lgG/lgM CLIA Assays Figure.2 Distribution of COVID-19 cases as of 15 March 2020 [4] sales@snibe.com w U s o n F ollo References:](https://static.documents.pub/doc/80x56/5f191a339ba1de097130452a/maglumi-2019-ncov-lgglgm-clia-assays-maglumi-2019-ncov-lgglgm-clia-assays-figure2.jpg)
